A melanina é a principal responsável pela pigmentação da pele. Sua produção pode afetar significativamente a uniformidade do tom da pele.²¹
Pacientes com pigmentação relacionada à acne³
Pacientes cuja pele apresentou um tom mais uniforme 15 meses após o tratamento⁵†
Uniformize o tom da pele com tratamentos específicos para pigmentação
Restylane® SKINBOOSTERS™ é o tratamento original e único com ácido hialurônico clinicamente comprovado para melhorar seis aspectos essenciais da qualidade da pele, incluindo uniformidade do tom de pele, com resultados que duram até 15 meses.5-18*
Encontre uma Clínica
Localize profissionais de saúde parceiros perto de você.
1.Fabi S, Alexiades M, Chatrath V, et al. Facial Aesthetic Priorities and Concerns: A Physician and Patient Perception Global Survey. Aesthetic Surgery Journal. 2022;42(4):NP218-NP229. doi:10.1093/asj/sjab358. 2. MedlinePlus. Skin Pigmentation Disorders. 3. Al-Qarqaz F et al. Dermatology Reports. 2021;13:8223. 4. Basit H, Godse KV, Al Aboud AM. Melasma. 2022. 5. Wu Y et al. J Cosmet Dermatol. 2020;19(7):1627–1635. 6. Qian W et al. J Cosmet Dermatol. 2018;17(4):596–599. 7. Williams S et al. J Cosmet Dermatol. 2009;8(3):216–225. 8. Ribé A et al. J Cosmet Laser Ther. 2011;13(4):154–161. 9. Lee BM et al. Arch Plast Surg. 2015;42(3):282–287. 10. Lim H-K et al. J Cosmet Laser Ther. 2014;16(1):32–36. 11. Kim J. Arch Aesthetic Plast Surg. 2014;20(2):97–103. 12. Gubanova EI et al. Poster presented at IMCAS, Jan–Feb 2015, Paris, France. 13. Gubanova EI et al. J Drugs Dermatol. 2015;14(3):288–299. 14. Kerscher M et al. Dermatol Surg. 2008;34(5):720–726. 15. Dierickx C et al. Dermatol Surg. 2018;44 Suppl 1:S10–S18. 16. Gubanova EI et al. Aesthetic Med. 2010;1:94–98. 17. Belmontesi M et al. J Drugs Dermatol. 2018;17(1):83–88. 18. Data on File. MA-54615. Restylane SKINBOOSTERS Competitor Comparison. Benching document 2022. 19. Restylane® Skinboosters™ VITAL EU IFU. 2020. 20. Restylane® Skinboosters™ VITAL LIGHT EU IFU.
* In a 15-month randomized, multicenter, evaluator-blinded, split-hand, no treatment-controlled study, 100 Chinese patients received treatment with Restylane® SKINBOOSTERS™ VITAL to treat one dorsal hand. During the study period, three treatments were administered in the same hand starting with initial treatment and then spaced 1 month apart.4 † 80.6%; compared with before having treatment with Restylane® SKINBOOSTERS™ VITAL, as assessed by Subject Satisfaction Questionnaire. 100 patients formed the intent-to-treat population. N=total sample number.4 ‡ In single-center, prospective, randomized, split-face, clinical study, 10 Korean patients received intradermal injection of Restylane® SKINBOOSTERS™ VITAL in the nasojugal groove. Treatment was given in 1 session. Assessments were performed before, immediately after, and at all follow-up visits. The effect of skin tone correction was assessed by spectrophotometer and mexameter at every visit. Peak correction was observed at 4-week follow-up.5 21. Lambert MW, et al. The physiology of melanin deposition in health and disease. Clinics in Dermatology. 2020;38(2):81–89. doi:10.1016/j.clindermatol.2019.07.013. PMID: 31896398.
BR-RES-2600153 | JUL/26
Consulte sempre um profissional de saúde habilitado para obter recomendações de tratamento individualizadas e para discutir informações importantes sobre segurança e riscos associados ao uso dos produtos.